Fujimi A - Search Results

1

A patient with paroxysmal nocturnal haemoglobinuria in whom granulocyte colony-stimulating factor administration resulted in improvement of recurrent enterocolitis and its associated haemolytic attacks.

Fujimi A, Matsunaga T, Kogawa K, Ohnuma T, Takahira N, Abe T, Kitaoka K, Kogawa T, Tanaka I, Morii K, Terui T, Sakamaki S, Kato J, Kura T, Maeda T, Niitsu Y. Fujimi A, et al. Br J Haematol. 2002 Dec;119(3):858-62. doi: 10.1046/j.1365-2141.2002.03914.x. Br J Haematol. 2002. PMID: 12437672 Free article.

2

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603.

Lu Y, Sakamaki S, Kuroda H, Kusakabe T, Konuma Y, Akiyama T, Fujimi A, Takemoto N, Nishiie K, Matsunaga T, Hirayama Y, Kato J, Kon S, Kogawa K, Niitsu Y. Lu Y, et al. Among authors: fujimi a. Blood. 2001 Feb 15;97(4):1123-30. doi: 10.1182/blood.v97.4.1123. Blood. 2001. PMID: 11159546 Free article.

3

Long-term survival and late-onset complications of cancer patients treated with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.

Kohda K, Sakamaki S, Matsunaga T, Kuga T, Fujimi A, Konuma Y, Kusakabe T, Kogawa K, Akiyama T, Koike K, Hirayama Y, Sasagawa Y, Nojiri S, Hirata Y, Nishisato T, Niitsu GY; Hokkaido Society of Peripheral Blood Stem Cell Transplantation. Kohda K, et al. Among authors: fujimi a. Int J Hematol. 2001 Feb;73(2):251-7. doi: 10.1007/BF02981946. Int J Hematol. 2001. PMID: 11372740 Clinical Trial.

4

[Mixed warm and cold antibody-type autoimmune hemolytic anemia in a healthy pregnant woman with primary cytomegalovirus infection].

Matsunaga T, Fujimi A, Takahira N, Miyajima N, Terui T, Kogawa K, Sakamaki S, Hirayama Y, Nagai T, Koyama R, Niitsu Y. Matsunaga T, et al. Among authors: fujimi a. Rinsho Ketsueki. 2002 Jan;43(1):29-34. Rinsho Ketsueki. 2002. PMID: 11868362 Japanese.

5

[Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis].

Takahari D, Matsunaga T, Fujimi A, Kikuchi T, Seki R, Tanaka I, Takemoto N, Akiyama T, Sato T, Terui T, Kogawa K, Kato J, Kura T, Maeda T, Niitsu Y. Takahari D, et al. Among authors: fujimi a. Rinsho Ketsueki. 2002 Oct;43(10):924-30. Rinsho Ketsueki. 2002. PMID: 12462028 Japanese.

6

[Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis].

Fujimi A, Matsunaga T, Ohnishi R, Takemoto N, Tanaka I, Akiyama T, Sato T, Morii K, Terui T, Kogawa K, Kato J, Hirayama M, Ohmi N, Sakamaki S, Niitsu Y. Fujimi A, et al. Rinsho Ketsueki. 2002 Nov;43(11):998-1003. Rinsho Ketsueki. 2002. PMID: 12508486 Japanese.

7

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.

Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, Akiyama T, Kuroda H, Kawano Y, Kobune M, Kato J, Hirayama Y, Sakamaki S, Kohda K, Miyake K, Niitsu Y. Matsunaga T, et al. Among authors: fujimi a. Nat Med. 2003 Sep;9(9):1158-65. doi: 10.1038/nm909. Epub 2003 Aug 3. Nat Med. 2003. PMID: 12897778 Free article.

8

C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective.

Matsunaga T, Kogawa K, Fujimi A, Takizawa K, Takahira N, Takemoto N, Tanaka I, Akiyama T, Sato T, Takayama T, Terui T, Sakamaki S, Niitsu Y. Matsunaga T, et al. Among authors: fujimi a. Int J Clin Oncol. 2003 Oct;8(5):326-31. doi: 10.1007/s10147-003-0327-7. Int J Clin Oncol. 2003. PMID: 14586760

9

[Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)].

Murase K, Matsunaga T, Takimoto R, Takahira N, Fujimi A, Takeuchi N, Terui T, Niitsu Y. Murase K, et al. Among authors: fujimi a. Rinsho Ketsueki. 2004 May;45(5):383-6. Rinsho Ketsueki. 2004. PMID: 15199747 Japanese.

10

[Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib].

Murase K, Matsunaga T, Takeuchi N, Fujimi A, Takimoto R, Terui T, Hirayama Y, Niitsu Y. Murase K, et al. Among authors: fujimi a. Rinsho Ketsueki. 2004 Sep;45(9):1028-32. Rinsho Ketsueki. 2004. PMID: 15510830 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page